Vertex Pharmaceuticals Incorporated VRTX
Set alert
536.49 USD -16.66 -3.01%
As of Nov 3, 10:39 AM ET
534.76 Day range 561.96
409.47 52-week range 558.88
- YTD
- +18.34%
- 1 year
- +25.94%
- Open
- 558.44
- Prev close
- 553.15
- Mkt cap
- 135.92B
- Vol
- 745.27K
- Avg vol
- 1.22M
- EPS
- 17.17
- P/E
- 31.23
- Div yield
- 0.00%
More statistics
- Low
- 534.76
- High
- 561.96
- Forward P/E
- 27.09
- Beta
- 0.28
- Short ratio
- 3.66
- Inst. own
- 98.10%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 11, 2027
- 50-d avg
- 523.21
- 200-d avg
- 479.21
- 1y target
- 571.46
MAX chart
Events in this range
- Nov 3, 2025Earnings: 4.8; estimate 4.57; surprise 5.03%
- May 4, 2026Earnings: 4.47; estimate 4.24; surprise 5.42%
- Aug 3, 2026Earnings: 4.73; estimate 4.74; surprise -0.21%
- Aug 4, 2026Rating: Cantor Fitzgerald · Overweight → Overweight
- Aug 4, 2026Rating: TD Cowen · Buy → Buy
- Aug 5, 2026Rating: Barclays · Overweight → Overweight
- Aug 5, 2026Rating: Truist Securities · Buy → Buy
- Nov 2, 2026Earnings: 4.76; estimate 4.82; surprise -1.24%
Signals (166)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Aug 1, 2026 | 3 months ago |
| SMA: Bullish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 1, 2026 | 6 months ago |
| SMA: Bearish | Apr 1, 2026 | 7 months ago |
| SMA: Bearish | Apr 1, 2026 | 7 months ago |
| SMA: Bullish | Dec 1, 2025 | 11 months ago |
| SMA: Bullish | Oct 1, 2025 | 1 year ago |
| SMA: Bearish | Aug 1, 2025 | 1 year ago |
| SMA: Bearish | May 1, 2025 | 1 year ago |
| SMA: Bullish | Jan 1, 2025 | 1 year ago |
| SMA: Bearish | Dec 1, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 1, 2024 | 1 year ago |
| RSI: Overbought | May 1, 2024 | 2 years ago |
| RSI: Overbought | Dec 1, 2023 | 2 years ago |
| SMA: Bullish | Mar 1, 2023 | 3 years ago |
| SMA: Bearish | Feb 1, 2023 | 3 years ago |
| RSI: Overbought | Oct 1, 2022 | 4 years ago |
| MACD: Buy Signal | Mar 1, 2022 | 4 years ago |
| SMA: Bullish | Jan 1, 2022 | 4 years ago |
| SMA: Bullish | Dec 1, 2021 | 4 years ago |
Newest 20 of 166.
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 12.00B | 11.02B | 9.87B | 8.93B | 7.57B | |
| 10.35B | 9.49B | 8.61B | 7.85B | 6.67B | |
| 4.18B | -233.40M | 3.78B | 4.25B | 2.78B | |
| 3.95B | -535.60M | 3.62B | 3.32B | 2.34B | |
| 15.32 | -2.08 | 13.89 | 12.82 | 9.01 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 5.08B | 4.57B | 10.37B | 10.50B | 6.79B | |
| 25.64B | 22.53B | 22.73B | 18.15B | 13.43B | |
| 6.98B | 6.12B | 5.15B | 4.24B | 3.33B | |
| 1.85B | 1.54B | 724.70M | 810.30M | 887.20M | |
| 18.67B | 16.41B | 17.58B | 13.91B | 10.10B |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 3.63B | -492.60M | 3.54B | 4.13B | 2.64B | |
| -945.40M | -3.77B | -3.14B | -321.10M | -340.90M | |
| -2.26B | -1.49B | -562.20M | -67.70M | -1.48B | |
| -437.60M | -297.70M | -200.40M | -204.70M | -235.00M | |
| 515.60M | -5.80B | -139.70M | 3.71B | 811.20M |